FindTrial
Sign In

Importance of Garbhini Ahar Vihar in Gestational Hypertension

Evaluation of the effect of Rasaja Bhava in Garbha amongst Gestational Hypertensive Females - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087174
Enrollment
100
Registered
2025-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O164- Unspecified maternal hypertension,complicating childbirth Health Condition 2: O169- Unspecified maternal hypertension,unspecified trimester

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Gestational Hypertension PNC patients upto 10 days post partum Primigravida as well as Multigravida

Exclusion criteria

Exclusion criteria: Known case of Hypothyroidism, Hyperthyroidism, Cardio Vascular Diseases, Diabetes Mellitus Any congenital disorder Pre existing Hypertension

Design outcomes

Primary

MeasureTime frame
To observe corelation between Rasaja Bhava and Gestational HypertensionTimepoint: information regarding Ahara Vihara taken during Pregnancy will be asked through a prevalidated Questionnaire upto first week of PNC—

Secondary

MeasureTime frame
To find out the Aharaj Viharaj hetu causing Gestational HypertensionTimepoint: information regarding Ahara Vihara taken during Pregnancy will be asked through a prevalidated Questionnaire upto first week of PNC—

Countries

India

Contacts

Public ContactDr Madhulika D Tiwari

Dr. D Y Patil College of Ayurved and Research Centre

madhulika.tiwari@dpu.edu.in9158350066

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026